Log in

NYSE:DHRDanaher Stock Price, Forecast & News

$185.48
+1.06 (+0.57 %)
(As of 07/9/2020 04:00 PM ET)
Add
Compare
Today's Range
$183.30
Now: $185.48
$187.19
50-Day Range
$157.66
MA: $170.49
$184.42
52-Week Range
$119.60
Now: $185.48
$187.19
Volume2.22 million shs
Average Volume2.36 million shs
Market Capitalization$129.37 billion
P/E Ratio42.15
Dividend Yield0.39%
Beta0.92
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments; Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology and molecular diagnostics products. This segment offers analytical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides equipment, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia. Cepheid, a company which is developing a faster test for COVID-19, is a subsidiary of Danaher.
Read More
Danaher logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.4Community Rank: 3.1Dividend Strength: 1.7Insider Behavior: 4.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.36 out of 5 stars


Industry, Sector and Symbol

Industry Process control instruments
Sub-IndustryIndustrial Conglomerates
CUSIP23585110
Phone202-828-0850

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$17.91 billion
Cash Flow$6.25 per share
Book Value$39.93 per share

Profitability

Net Income$3.01 billion

Miscellaneous

Employees60,000
Market Cap$129.37 billion
Next Earnings Date7/16/2020 (Estimated)
OptionableOptionable

Receive DHR News and Ratings via Email

Sign-up to receive the latest news and ratings for DHR and its competitors with MarketBeat's FREE daily newsletter.

Danaher (NYSE:DHR) Frequently Asked Questions

How has Danaher's stock been impacted by COVID-19 (Coronavirus)?

Danaher's stock was trading at $139.37 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, DHR shares have increased by 33.1% and is now trading at $185.48. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Danaher?

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Danaher in the last year. There are currently 3 hold ratings and 10 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Danaher.

When is Danaher's next earnings date?

Danaher is scheduled to release its next quarterly earnings announcement on Thursday, July 16th 2020. View our earnings forecast for Danaher.

How were Danaher's earnings last quarter?

Danaher Co. (NYSE:DHR) announced its quarterly earnings data on Wednesday, May, 6th. The conglomerate reported $1.05 EPS for the quarter, topping the consensus estimate of $1.00 by $0.05. The conglomerate earned $4.34 billion during the quarter, compared to analyst estimates of $4.32 billion. Danaher had a return on equity of 11.52% and a net margin of 16.85%. The company's revenue for the quarter was up 2.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.07 EPS. View Danaher's earnings history.

How often does Danaher pay dividends? What is the dividend yield for Danaher?

Danaher announced a quarterly dividend on Tuesday, May 5th. Shareholders of record on Friday, June 26th will be given a dividend of $0.18 per share on Friday, July 31st. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.39%. The ex-dividend date is Thursday, June 25th. View Danaher's dividend history.

What guidance has Danaher issued on next quarter's earnings?

Danaher issued an update on its first quarter 2020 Pre-Market earnings guidance on Monday, April, 13th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $5.026-5.026 billion, compared to the consensus revenue estimate of $4.28 billion.

What price target have analysts set for DHR?

13 Wall Street analysts have issued 12 month price targets for Danaher's stock. Their forecasts range from $136.00 to $195.00. On average, they anticipate Danaher's stock price to reach $172.00 in the next twelve months. This suggests that the stock has a possible downside of 7.3%. View analysts' price targets for Danaher.

Has Danaher been receiving favorable news coverage?

Media stories about DHR stock have been trending negative this week, InfoTrie Sentiment reports. InfoTrie identifies negative and positive news coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Danaher earned a daily sentiment score of -2.3 on InfoTrie's scale. They also assigned media stories about the conglomerate a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the next few days. View the latest news about Danaher.

Who are some of Danaher's key competitors?

What other stocks do shareholders of Danaher own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Danaher investors own include NVIDIA (NVDA), Home Depot (HD), Walt Disney (DIS), Cisco Systems (CSCO), Adobe (ADBE), Johnson & Johnson (JNJ), Alibaba Group (BABA), Intel (INTC), Alphabet (GOOG) and CVS Health (CVS).

Who are Danaher's key executives?

Danaher's management team includes the following people:
  • Mr. Thomas P. Joyce Jr., CEO, Pres & Director (Age 59)
  • Mr. Daniel L. Comas, Exec. VP (Age 56)
  • Mr. William K. Daniel II, Exec. VP (Age 55)
  • Mr. Rainer M. Blair, Exec. VP (Age 56)
  • Mr. Joakim Weidemanis, Exec. VP (Age 50)

What is Danaher's stock symbol?

Danaher trades on the New York Stock Exchange (NYSE) under the ticker symbol "DHR."

Who are Danaher's major shareholders?

Danaher's stock is owned by many different institutional and retail investors. Top institutional investors include Envestnet Asset Management Inc. (0.11%), Robecosam AG (0.05%), Mountain Pacific Investment Advisers Inc. ID (0.05%), Riverbridge Partners LLC (0.05%), Capital Investment Services of America Inc. (0.02%) and Park National Corp OH (0.02%). Company insiders that own Danaher stock include Alan G Spoon, Angela S Lalor, Brian W Ellis, Daniel L Comas, Daniel Raskas, Donald J Ehrlich, Linda P Hefner, Matthew Mcgrew, Mitchell P Rales, Rainer Blair, Robert S Lutz, Thomas Patrick Joyce Jr, Walter G Lohr, William K Daniel and William King. View institutional ownership trends for Danaher.

Which major investors are selling Danaher stock?

DHR stock was sold by a variety of institutional investors in the last quarter, including Robecosam AG, Mountain Pacific Investment Advisers Inc. ID, Chesley Taft & Associates LLC, State of Alaska Department of Revenue, Renaissance Investment Group LLC, Nexus Investment Management ULC, Park National Corp OH, and Addenda Capital Inc.. Company insiders that have sold Danaher company stock in the last year include Angela S Lalor, Brian W Ellis, Daniel L Comas, Daniel Raskas, Donald J Ehrlich, Linda P Hefner, Matthew Mcgrew, Rainer Blair, Robert S Lutz, Thomas Patrick Joyce Jr, Walter G Lohr, William K Daniel, and William King. View insider buying and selling activity for Danaher.

Which major investors are buying Danaher stock?

DHR stock was bought by a variety of institutional investors in the last quarter, including Envestnet Asset Management Inc., Canandaigua National Corp, Riverbridge Partners LLC, DNB Asset Management AS, Mount Yale Investment Advisors LLC, Patton Fund Management Inc., Windsor Group LTD, and Modus Advisors LLC. View insider buying and selling activity for Danaher.

How do I buy shares of Danaher?

Shares of DHR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Danaher's stock price today?

One share of DHR stock can currently be purchased for approximately $185.48.

How big of a company is Danaher?

Danaher has a market capitalization of $129.37 billion and generates $17.91 billion in revenue each year. The conglomerate earns $3.01 billion in net income (profit) each year or $4.42 on an earnings per share basis. Danaher employs 60,000 workers across the globe.

What is Danaher's official website?

The official website for Danaher is www.danaher.com.

How can I contact Danaher?

Danaher's mailing address is 2200 PENNSYLVANIA AVE. N.W SUITE 800W, WASHINGTON DC, 20037. The conglomerate can be reached via phone at 202-828-0850 or via email at [email protected]

This page was last updated on 7/10/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.